# PMS to Evaluate the Safety and Efficacy of Picato® Gel

> **NCT02421471** · — · COMPLETED · sponsor: **LEO Pharma** · enrollment: 1324 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Ingenol mebutate 0.015 percent or 0.05 percent gel

## Key facts

- **NCT ID:** NCT02421471
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2018-01-19
- **Final completion:** 2018-01-19
- **Target enrollment:** 1324 (ACTUAL)
- **Last updated:** 2019-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02421471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02421471, "PMS to Evaluate the Safety and Efficacy of Picato® Gel". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02421471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*